Potential of anti-inflammatory treatment for cystic fibrosis lung disease

Ítems similars

• The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
  per: Sherstin T. Lommatzsch, et al.
  Publicat: (2019-04-01)
• The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
  per: Lommatzsch, Sherstin T., et al.
  Publicat: (2019)
• Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease
  per: Voynow, Judith A., et al.
  Publicat: (2020)
• Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease
  per: Alexander L. Pukhalsky, et al.
  Publicat: (2004-01-01)
• Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease.
  per: Pukhalsky, Alexander L, et al.
  Publicat: (2004)